Entrada Therapeutics, Inc.Entrada Therapeutics, Inc.Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.

No trades
See on Supercharts

TRDA fundamentals

An in-depth look to Entrada Therapeutics, Inc. operating, investing, and financing activities

TRDA free cash flow for Q3 24 is -24.91 M USD. For 2023, TRDA free cash flow was 134.19 M USD and operating cash flow was 139.8 M USD.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth